son of T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : son of T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (485)	1/22/2000 8:49:00 PM
From: Jim Oravetz	Read Replies (2) of 673

FDA halts work at gene-therapy lab Investigation into teen's death uncovers research violations By Rick Weiss and Deborah Nelson WASHINGTON POST Jan. 22 The federal government Friday halted all human gene therapy experiments involving a prominent researcher at the University of Pennsylvania, saying an investigation into the September death of a teenager there found the school's prestigious program in serious disarray. ...18-year-old Jesse Gelsinger into the study even though he was not healthy enough to qualify. Gelsinger died from the treatment Sept. 17, in what is believed to be the first death caused directly by gene therapy.... ...Penn's institute is one of the largest academic gene therapy centers in the world, with an annual budget of about $25 million and links with private biotechnology companies. Wilson, who is a key investigator in all seven gene therapy studies suspended by the FDA, has come under increased scrutiny in the months since Gelsinger's death, in part because of revelations that he had a potentially large financial stake in the outcome of the Gelsinger study..... "If Gelsinger was never told that four people before him had Grade 3 [serious] toxicities and that monkeys had been killed by this kind of treatment, then you have to ask, did he really give informed consent or did he just give consent?" asked Leon Rosenberg, a geneticist at Princeton University who pioneered research on Gelsinger's disease. washingtonpost.com Sounds like the people at Penn are/were running a pretty low quality operation their. Some serious lack of both ethical and professional conduct. They deserve to be shut down. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next